Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BIOCON.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
0.84
vs NA
Q3.23
+169%
1.05
vs 0.39
Q4.23
+844%
2.59
vs -0.35
Q1.24
N/A
NA
vs 2.61
Q2.24
+24%
1.05
vs 0.84
Q3.24
+408%
5.33
vs 1.05
Q4.24
-54%
1.2
vs 2.59
Q1.25
N/A
NA
vs NA
Q2.25
+34%
1.41
vs 1.05
Q3.25
-90%
0.55
vs 5.33
Sales Growth
YoY
Current
Estimates
Q2.23
+60%
34.2B vs 21.4B
Q3.23
+49%
34.6B vs 23.2B
Q4.23
+21%
35.5B vs 29.4B
Q1.24
+4%
39.2B vs 37.7B
Q2.24
+0%
34.3B vs 34.2B
Q3.24
+2%
35.5B vs 34.6B
Q4.24
+6%
37.7B vs 35.5B
Q1.25
+14%
44.5B vs 39.2B
Q2.25
+14%
39.2B vs 34.3B
Q3.25
+3%
36.4B vs 35.5B
Return on Equity
QoQ
Q2.23
+1%
0.01
vs 0.02
Q3.23
+1%
0.01
vs 0.01
Q4.23
+3%
0.03
vs 0.01
Q1.24
+1%
0.01
vs 0.03
Q2.24
+3%
0.03
vs 0.01
Q3.24
0%
-0.00
vs 0.03
Q4.24
+0%
0
vs -0.00
Q1.25
+2%
0.02
vs 0
Institutionnal Ownership
QoQ
Q1.23
1
1
vs NA
NA
Q2.23
1
1
vs 1
NA
Q3.23
1
1
vs 1
NA
Q4.23
1
1
vs 1
NA
Q1.24
2
2
vs 1
100%
Q2.24
2
2
vs 2
NA
Q4.24
1
1
vs NA
NA
Q1.25
1
1
vs 1
NA
Quote Panel
Key Metrics
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
BIOCON.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How BIOCON.NS compares to sector?
BIOCON.NS
40x